Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

Alexandre Mebazaa, Gad Cotter, Christopher Edwards et al.|The Lancet|2022

Cited by 1k